- Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer
[作者：Stephenson, AJ; Bosl, GJ; Motzer, RJ; Bajorin, DF; Stasi, JP; Sheinfeld, J,期刊：Journal of clinical oncology, 页码：5597-5602 , 文章类型： Article，,卷期：2007年25-35]
- PurposePatients with clinical stage (CS) IIA and IIB nonseminomatous germ cell tumor (NSGCT) with adenopathy more than 2 cm, multiple masses, elevated serum tumor markers, or disease outside the primary landing zone have...
- Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors
[作者：Carver, BS; Serio, AM; Bajorin, D; Motzer, RJ; Stasi, J; Bosl, GJ; Vickers, AJ; Sheinfeld, J,期刊：Journal of clinical oncology, 页码：5603-5608 , 文章类型： Article，,卷期：2007年25-35]
- PurposeThe integration of chemotherapy and surgery for metastatic nonseminomatous germ cell tumors (NSGCT) results in survival rates of greater than 80% overall. We evaluated men undergoing postchemotherapy retroperitone...
- Three-gene prognostic classifier for early-stage non-small-cell lung cancer
[作者：Lau, SK; Boutros, PC; Pintilie, M; Blackhall, FH; Zhu, CQ; Strumpf, D; Johnston, MR; Darling, G; Keshavjee, S; Waddell, TK; Liu, N; Lau, D; Penn, LZ; Shepherd, FA; Jurisica, I; Der, SD; Tsao, MS,期刊：Journal of clinical oncology, 页码：5562-5569 , 文章类型： Article，,卷期：2007年25-35]
- PurposeSeveral microarray studies have reported gene expression signatures that classify non-small-cell lung carcinoma (NSCLC) patients into different prognostic groups. However, the prognostic gene lists reported to dat...
- Lung cancer in elderly patients: An analysis of the surveillance, epidemiology, and end results database
[作者：Owonikoko, TK; Ragin, CC; Belani, CP; Oton, AB; Gooding, WE; Taioli, E; Ramalingam, SS,期刊：Journal of clinical oncology, 页码：5570-5577 , 文章类型： Article，,卷期：2007年25-35]
- PurposeTo study the burden and outcome of lung cancer in the elderly, particularly for patients aged 80 years and older.Patients and MethodsThe national Surveillance, Epidemiology, and End Results database was analyzed f...
- Panel of serum biomarkers for the diagnosis of lung cancer
[作者：Patz, EF; Campa, MJ; Gottlin, EB; Kusmartseva, I; Guan, XR; Herndon, JE,期刊：Journal of clinical oncology, 页码：5578-5583 , 文章类型： Article，,卷期：2007年25-35]
- PurposeCurrently, a blood test for lung cancer does not exist. Serum biomarkers that could aid clinicians in making case management decisions would be enormously valuable. We used two proteomic platforms and a literature...
- Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients
[作者：Deng, G; Vickers, AJ; Yeung, KS; D'Andrea, GM; Xiao, H; Heerdt, AS; Sugarman, S; Troso-Sandoval, T; Seidman, AD; Hudis, CA; Cassileth, BR,期刊：Journal of clinical oncology, 页码：5584-5590 , 文章类型： Article，,卷期：2007年25-35]
- PurposeTo determine the immediate and long-term effects of true acupuncture versus sham acupuncture on hot flash frequency in women with breast cancer.Patients and MethodsSeventy-two women with breast cancer experiencing...
- Significance of multifocality in ductal carcinoma in situ: Outcomes of women treated with breast-conserving therapy
[作者：Rakovitch, E; Pignol, JP; Hanna, W; Narod, S; Spayne, J; Nofech-Mozes, S; Chartier, C; Paszat, L,期刊：Journal of clinical oncology, 页码：5591-5596 , 文章类型： Article，,卷期：2007年25-35]
- PurposeThere is concern that women with multifocal ductal carcinoma in situ (DCIS; confined to one quadrant) who are treated with breast-conserving surgery face a high risk of local recurrence; therefore, many are treate...
- Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified?
[作者：Ferrone, CR; Tang, LH; Tomlinson, J; Gonen, M; Hochwald, SN; Brennan, MF; Klimstra, DS; Allen, PJ,期刊：Journal of clinical oncology, 页码：5609-5615 , 文章类型： Article，,卷期：2007年25-35]
- PurposeThe WHO classification for well-differentiated pancreatic endocrine neoplasms (PENs) incorporates both stage and grade. This study compares the prognostic value of a simplified staging and grading system with the ...
- Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia
[作者：Hillmen, P; Skotnicki, AB; Robak, T; Jaksic, B; Dmoszynska, A; Wu, JY; Sirard, C; Mayer, J,期刊：Journal of clinical oncology, 页码：5616-5623 , 文章类型： Article，,卷期：2007年25-35]
- PurposeWe conducted a randomized trial to evaluate the efficacy and safety of intravenous alemtuzumab compared with chlorambucil in first-line treatment of chronic lymphocytic leukemia (CLL).Patients and MethodsPatients ...
- Computed tomography scans do not improve the predictive power of 1996 national cancer institute-sponsored working group chronic lymphocytic leukemia response criteria
[作者：Blum, KA; Young, D; Broering, S; Lucas, MS; Fischer, B; Lin, TS; Grever, MR; Byrd, JC,期刊：Journal of clinical oncology, 页码：5624-5629 , 文章类型： Article，,卷期：2007年25-35]
- PurposeNational Cancer Institute-sponsored Working Group (NCI-WG) response criteria for chronic lymphocytic leukemia (CLL) rely on physical examination, blood, and bone marrow evaluations. The widespread use of computed ...
- Familial chronic myeloproliferative disorders: Clinical phenotype and evidence of disease anticipation
[作者：Rumi, E; Passamonti, F; Della Porta, MG; Elena, C; Arcaini, L; Vanelli, L; Del Curto, C; Pietra, D; Boveri, E; Pascutto, C; Cazzola, M; Lazzarino, M,期刊：Journal of clinical oncology, 页码：5630-5635 , 文章类型： Article，,卷期：2007年25-35]
- PurposeChronic myeloproliferative disorders (CMDs) have sporadic occurrence. However, familial clustering is reported. The purpose of this study was to assess the prevalence and the clinical phenotype of familial CMDs, a...
- Hope and prognostic disclosure
[作者：Mack, JW; Wolfe, J; Cook, EF; Grier, HE; Cleary, PD; Weeks, JC,期刊：Journal of clinical oncology, 页码：5636-5642 , 文章类型： Article，,卷期：2007年25-35]
- PurposePhysicians sometimes selectively convey prognostic information to support patients' hopes. However, the relationship between prognostic disclosure and hope is not known.Patients and MethodsWe surveyed 194 parents ...
- Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning
[作者：Ganti, AK; Lee, SJ; Vose, JM; Devetten, MP; Bociek, RG; Armitage, JO; Bierman, PJ; Maness, LJ; Reed, EC; Loberiza, FR,期刊：Journal of clinical oncology, 页码：5643-5648 , 文章类型： Article，,卷期：2007年25-35]
- PurposeEngagement in advance care planning (ACP) is viewed as a way to prepare for possible death. In patients undergoing hematopoietic stem-cell transplantation (HSCT), an aggressive but possibly curative procedure for ...
|